Praram 9 Hospital PCL (BKK:PR9)

Praram 9 Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	5,011	4,649	4,216	4,122	3,000	2,613
Other Revenue	48.98	41.51	36.86	28.16	26.12	19.93
Revenue	5,060	4,691	4,253	4,150	3,026	2,633
Revenue Growth (YoY)	13.78%	10.29%	2.47%	37.16%	14.93%	-8.46%
Cost of Revenue	3,194	3,045	2,820	2,724	2,172	1,890
Gross Profit	1,866	1,645	1,433	1,427	853.75	743.22
Selling, General & Admin	947.42	837.22	773.68	735.1	557.21	518.42
Operating Expenses	947.42	837.22	773.68	735.1	557.21	518.42
Operating Income	918.45	807.89	659.09	691.81	296.53	224.8
Interest Expense	-0.4	-0.49	-0.64	-0.48	-0.48	-0.47
Interest & Investment Income	57.67	54.62	30.17	8.72	4.21	5.94
Pretax Income	975.72	862.01	688.63	700.05	300.27	230.28
Income Tax Expense	178.67	149.33	130.77	132.44	51.1	28.22
Net Income	797.05	712.68	557.86	567.61	249.17	202.05
Net Income to Common	797.05	712.68	557.86	567.61	249.17	202.05
Net Income Growth	27.29%	27.75%	-1.72%	127.80%	23.32%	-28.97%
Shares Outstanding (Basic)	786	786	786	786	786	786
Shares Outstanding (Diluted)	786	786	786	786	786	786
EPS (Basic)	1.01	0.91	0.71	0.72	0.32	0.26
EPS (Diluted)	1.01	0.91	0.71	0.72	0.32	0.26
EPS Growth	27.29%	27.75%	-1.72%	127.80%	23.32%	-28.97%
Free Cash Flow	858.6	804.87	514.74	736.32	344.49	-304.26
Free Cash Flow Per Share	1.09	1.02	0.66	0.94	0.44	-0.39
Dividend Per Share	0.250	0.400	0.300	0.290	0.140	0.110
Dividend Growth	-44.44%	33.33%	3.45%	107.14%	27.27%	-21.43%
Gross Margin	36.87%	35.07%	33.69%	34.38%	28.21%	28.23%
Operating Margin	18.15%	17.22%	15.50%	16.67%	9.80%	8.54%
Profit Margin	15.75%	15.19%	13.12%	13.68%	8.23%	7.67%
Free Cash Flow Margin	16.97%	17.16%	12.10%	17.74%	11.39%	-11.56%
EBITDA	1,210	1,097	941.45	974.8	570.13	416.91
EBITDA Margin	23.91%	23.39%	22.14%	23.49%	18.84%	15.83%
D&A For EBITDA	291.2	289.25	282.35	282.98	273.6	192.11
EBIT	918.45	807.89	659.09	691.81	296.53	224.8
EBIT Margin	18.15%	17.22%	15.50%	16.67%	9.80%	8.54%
Effective Tax Rate	18.31%	17.32%	18.99%	18.92%	17.02%	12.26%
Revenue as Reported	5,060	4,691	4,253	4,150	3,026	2,633

Source: S&P Global Market Intelligence. Standard template. Financial Sources.